[go: up one dir, main page]

JPH0832225B2 - Microcapsule manufacturing method - Google Patents

Microcapsule manufacturing method

Info

Publication number
JPH0832225B2
JPH0832225B2 JP2235636A JP23563690A JPH0832225B2 JP H0832225 B2 JPH0832225 B2 JP H0832225B2 JP 2235636 A JP2235636 A JP 2235636A JP 23563690 A JP23563690 A JP 23563690A JP H0832225 B2 JPH0832225 B2 JP H0832225B2
Authority
JP
Japan
Prior art keywords
yeast
enzyme
cell wall
hydrophobic liquid
microcapsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2235636A
Other languages
Japanese (ja)
Other versions
JPH04117245A (en
Inventor
守 石黒
尚武 石脇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Mitsubishi Paper Mills Ltd
Original Assignee
Kirin Brewery Co Ltd
Mitsubishi Paper Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd, Mitsubishi Paper Mills Ltd filed Critical Kirin Brewery Co Ltd
Priority to JP2235636A priority Critical patent/JPH0832225B2/en
Priority to DE69113682T priority patent/DE69113682T2/en
Priority to EP91305102A priority patent/EP0460945B1/en
Publication of JPH04117245A publication Critical patent/JPH04117245A/en
Priority to US08/178,604 priority patent/US5521089A/en
Publication of JPH0832225B2 publication Critical patent/JPH0832225B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Color Printing (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention 【産業上の利用分野】[Industrial applications]

本発明は、酵母菌の細胞壁をマイクロカプセル皮膜と
して有するマイクロカプセルの製造方法に関するもので
ある。更に詳しくは使用目的に応じてマイクロカプセル
皮膜の物理的強度や皮膜特性を自由に制御し得るマイク
ロカプセルの製造方法に関するものである。
The present invention relates to a method for producing microcapsules having yeast cell walls as a microcapsule film. More specifically, the present invention relates to a method for producing microcapsules in which the physical strength and film characteristics of the microcapsule film can be freely controlled according to the purpose of use.

【従来の技術】[Prior art]

マイクロカプセルは1μm〜数百μmまでの大きさの
微粒子として液体、固体、気体を内包し、そのまわりを
薄い皮膜で均一に覆ったものであり、具体的には、無色
及び有色染料、医薬品、農薬、香料、飼料素材及び食品
素材等を内包させたマイクロカプセルが工業的に製品化
されている。 マイクロカプセルは、ある特性をもった物質の外側に
薄膜を形成させることでその特性も同時に封じ込めてし
まうことが可能で、必要時に皮膜を破壊すれば内包され
た物質を取り出すことができるものである。 従来より知られているマイクロカプセルの製造方法と
しては、 (1)ゼラチンによるコアセルベーション法(米国特許
第2800457号、同2800458号明細書など) (2)外相(水相)より皮膜を形成するin situ法(特
公昭36−9168号、同47−23165号、特開昭48−57892号、
同51−9079号、同54−49984号、同54−25277号公報等) (3)内相と外相間の皮膜形成反応を利用した界面重合
法 が有力な方法として知られている。 また、微生物を利用したマイクロカプセルの製造方法
として、次のものが知られている。例えば、米国特許第
4001480号明細書においては脂質含有量が40〜60%の真
菌類中に、その脂質に可溶性の物質をカプセル化する方
法が紹介されている。 さらに、特開昭58−107189号公報では、成長微生物の
脂質含量の増量方法として、培地から回収した脂質含量
10wt%以上の成長微生物(例えば油脂形成性酵母菌、麦
酒酵母菌など)に脂質増量用有機物質(例えば脂肪族ア
ルコール類、エステル類、芳香族炭化水素類、水添芳香
族炭化水素類)から選択される液体を包含せしめた後、
これら脂質増量用有機物質に可溶な芯物質となるべき液
体をカプセル化してなる微生物カプセルを挙げている。
Microcapsules are liquids, solids, and gases as fine particles having a size of 1 μm to several hundreds of μm, which are uniformly covered with a thin film, specifically, colorless and colored dyes, pharmaceuticals, Microcapsules containing pesticides, fragrances, feed materials, food materials, etc. are industrially commercialized. By forming a thin film on the outside of a substance with a certain property, the microcapsule can also contain that property at the same time, and if the film is destroyed when necessary, the encapsulated substance can be taken out. . Conventionally known methods for producing microcapsules include (1) a coacervation method using gelatin (US Pat. Nos. 2800457 and 2800458) (2) Forming a film from an external phase (aqueous phase) in situ method (Japanese Patent Publication No. 36-9168, No. 47-23165, JP-A-48-57892,
No. 51-9907, No. 54-49984, No. 54-25277, etc.) (3) An interfacial polymerization method utilizing a film-forming reaction between an internal phase and an external phase is known as an effective method. The following are known methods for producing microcapsules using microorganisms. For example, US Patent No.
4001480 describes a method of encapsulating a lipid-soluble substance in a fungus having a lipid content of 40 to 60%. Furthermore, in JP-A-58-107189, as a method for increasing the lipid content of growing microorganisms, the lipid content recovered from the medium is
From 10 wt% or more of growth microorganisms (eg, oil-forming yeasts, brewer's yeasts, etc.) to lipid-increasing organic substances (eg, aliphatic alcohols, esters, aromatic hydrocarbons, hydrogenated aromatic hydrocarbons) After including the liquid of choice,
There is mentioned a microbial capsule obtained by encapsulating a liquid which should be a core substance soluble in these lipid-increasing organic substances.

【発明が解決しようとする課題】[Problems to be Solved by the Invention]

上記カプセル化法においては、内包物の保護力に優れ
た緻密な皮膜を有するマイクロカプセルが得られ、工業
的にも広く応用されているものもあるが、製造面につい
て数々の問題点を有していることも事実である。すなわ
ち、(1)のコアセルベーション法については反応に係
わるpH、温度、時間操作が複雑であり、またカプセル化
工程に長時間を要する等の問題点を有する。 (2)のin situ法及び(3)の界面重合法について
は、反応性の高い皮膜基材を比較的高温で反応させるた
め、不安定な物質あるいは熱変性しやすい物質のカプセ
ル化には向かない、等の欠点を有している。 また、微生物を利用したマイクロカプセル化法は天然
物、しかも生物体の一部を素材として用い、カプセル化
のメカニズムも従来の方法とは全く性質を異にしたもの
である。しかし、これらの前記特許明細書中の実施例を
見るに、初期添加酵母菌(膜材)が内包し得る疎水性液
体の量が現在工業的に用いられている方法に比べ相対的
に少なく、しかも多量に摂取させようとすればカプセル
化に長時間を要するという欠点を有している。 本発明者らは、これらの提案に基づき、微生物を利用
したマイクロカプセルを作成し、感圧複写紙を製造し、
タイプライター筆記等による発色性の比較を行なったと
ころ、前記(1)コアセルベーション法や(2)in sit
u法により得られるマイクロカプセルと比較して皮膜と
なる部分の物理的強度が高いためか、得られたシート上
には同等量の染料が塗抹されているにもかかわらず相対
的に低い発色濃度しか得られず、特に多数枚の複写を得
ることは困難であった。 本発明は微生物を利用したマイクロカプセル化法にお
いて、単位菌体量に多量の疎水性液体を迅速に摂取し得
ることを可能にし、しかも通常の取扱い時には堅牢性に
富む皮膜であるが、内包された物質を取出したい際には
効率よく破壊し得る皮膜を有するマイクロカプセルの製
造方法を提供するものである。
In the above-mentioned encapsulation method, microcapsules having a dense film excellent in protective power of the inclusions can be obtained, and there are some that are widely applied industrially, but there are many problems in terms of production. It is also true. That is, in the coacervation method (1), there are problems that the pH, temperature and time operations involved in the reaction are complicated, and that the encapsulation process requires a long time. The in situ method (2) and the interfacial polymerization method (3) are suitable for encapsulation of unstable substances or substances that are easily thermally denatured because a highly reactive coating substrate is reacted at a relatively high temperature. It has drawbacks such as emptiness. In addition, the microencapsulation method using microorganisms uses a natural product, and part of the organism as a raw material, and the encapsulation mechanism is completely different from the conventional method. However, looking at the examples in these patent specifications, the amount of the hydrophobic liquid that can be encapsulated by the initially added yeast (membrane material) is relatively small compared to the method currently used industrially, Moreover, it has a drawback that encapsulation requires a long time if a large amount is to be ingested. Based on these proposals, the present inventors created microcapsules utilizing microorganisms, manufactured pressure-sensitive copying paper,
When the color development was compared by writing with a typewriter, the (1) coacervation method and (2) in sit
Probably because the physical strength of the film part is higher than that of the microcapsules obtained by the u method, the color density is relatively low even though the same amount of dye is smeared on the obtained sheet. However, it was difficult to obtain a large number of copies. INDUSTRIAL APPLICABILITY The present invention is a microencapsulation method utilizing a microorganism, which enables rapid ingestion of a large amount of hydrophobic liquid per unit cell amount, and is a film that is rich in robustness during normal handling, but is included. The present invention provides a method for producing microcapsules having a film that can be efficiently destroyed when it is desired to take out such substances.

【課題を解決するための手段】[Means for Solving the Problems]

本発明者らは、微生物を用いたカプセル化法の前記問
題点を解決するべく検討したところ、次の手法により解
決されることを見いだした。すなわち、本発明は酵母菌
体内に疎水性液体を内包してなるマイクロカプセルの製
造方法において、酵母菌の細胞壁を溶解する酵素で酵母
菌を処理することを特徴とするものである。以降、酵母
菌の細胞壁を溶解する酵素を酵母細胞壁溶解酵素と略称
する。 〈酵母菌〉 本発明で使用される酵母菌とは、出芽もしくは分裂に
より増殖する微生物の総称である。具体的には、例え
ば、 サッカロマイセス属の サッカロマイセス・セレビッシェ(Saccharomyces cere
visiae) サッカロマイセス・ルーキシ(Saccharomyces rouxii) サッカロマイセス・カールスバーゲンシス(Saccharomy
ces carlsbergensis) キャンディダ属の キャンディダ・ウティリス(Candida utilis) キャンディダ・トロピカリス(Candida tropicallis) キャンディダ・リポリティカ(Candida lypolytica) キャンディダ・フレーベリ(Candida flaveri) 等が使用できる。 酵母菌の形状は種類によって種々の形があるが、なる
べく球形に近い形態のものが好ましく、粒径は1〜20μ
mの範囲が好ましい。 本発明で用いられるこれら酵母菌は、生のままでも乾
燥した状態でもよく、さらに増殖能力のない死滅した状
態でもよい。 酵母菌は、必要に応じ適当な処理を行ったものでもよ
い。例えば、これらの母菌中には、水もしくは極性溶剤
に可溶性の酵素及びタンパク質、アミノ酸成分、糖成
分、核酸成分等の菌体内組織が存在しているが、疎水性
液体を多量に内包させるために、これら菌体内成分を種
々の方法で抽出処理した後の酵母菌残渣を用いることも
できる。 これらの酵母菌、もしくは酵母菌残渣は、必要に応じ
適当な分散剤を用い、水溶液中に分散される。 〈酵母細胞壁溶解酵素〉 本発明で用いられる酵母細胞壁溶解酵素は、プロテア
ーゼのような酵母菌体成分を溶出する酵素とは区別さ
れ、酵母細胞壁を溶解する酵素であればいずれでもよ
い。すなわち、酵母の細胞壁はグルカン、マンナン、及
びこれらの多糖類と蛋白の複合体、キチン等から構成さ
れ、これらの構成成分を分解する酵素であれば、いずれ
も用いることができる。本発明で用いられる細胞壁溶解
酵素としてはグルカナーゼ、マンナナーゼ、キチナーゼ
等が挙げられるが中でもグルカナーゼ、マンナナーゼが
好ましく、特にβ−1,3グルカナーゼを主成分とする微
生物が産生する酵素が好ましい。これらの酵素は単独で
用いてもよいし2種以上併用してもよい。これらの酵素
は試薬として入手することもできるし、これらの酵素を
主成分とする下記酵素としても入手できる。 アースロバクターの産生する酵素(キリンビール
(株)製ザイモリエース20T)、担子菌の産生する酵素
(クミアイ化学(株)製キタラーゼ)、アクロモバクタ
ーの産生する酵素(天野製薬(株)製YL−05)。 また、船津・鶴編「溶菌酵素」講談社(1977年)P.16
9〜191に記載の種々の細胞壁溶解酵素、その他を用いる
ことができる。 〈酵母細胞壁の溶解処理〉 溶解処理は、酵母細胞壁を部分的に溶解して薄膜化ま
たは軟化させるために行う。その程度は、製造したマイ
クロカプセルの用途に応じて、所望の物理的強度及び/
又は皮膜特性(例えば徐放性)が得られるよう細胞壁を
溶解させる。すなわち常法に従って酵母菌に酵母細胞壁
溶解酵素を作用させ、所望の皮膜強度等が得られるよう
な酵素の添加量、処理条件を設定するか、又は所望の皮
膜強度が得られた時点で酵素反応を停止させることによ
り行う。 通常多くの酵素の至適条件として、pHは4〜9、温度
は30〜60℃の範囲にあり、酵素の添加量も基質1gに対し
0.1〜100mgの範囲で用いられる。反応時間は上記条件に
よって最適時間が設定されるが通常約10分以上、好まし
くは約30分〜約5時間である。酵素反応の停止方法は、
遠心分離、洗浄などにより酵母菌と酵素を分離する方
法、加熱、pH調整、あるいは失活剤などにより酵素を失
活させる方法、その他適当な方法を用いればよいが、酵
母細胞壁の損傷、劣化を生じない方法が選択される。具
体的な酵素反応の停止時点は、製造したマイクロカプセ
ルの中から目的の用途に適するマイクロカプセルが得ら
れる条件を選べば良い。酵母菌細胞壁がどの程度溶解し
たかは、酵素反応により細胞壁は糖に分解されるため、
酵母菌分散液のろ液中に存在する全糖量を定量すること
により判断できる。例えば感圧複写紙用のマイクロカプ
セルの場合にはカプセルが熱、湿度、あるいはまた各種
印刷、帳票作業時に破壊されないことが必要である。こ
れら通常の取り扱い工程において充分なカプセルの堅牢
性を発揮するためには糖溶出率(実施例参照)を約0.5
〜約40%、特に約1%〜約20%に調整することが好まし
い。糖溶出率がこの範囲以下の値であると本発明の効果
は充分には発現せず、この範囲より高い値に溶出させた
ものは得られたカプセルの皮膜の堅牢性に乏しいものと
なり、例えば感圧複写紙用に加工した場合には、熱、湿
度、溶剤等の外的要因によって壊れ易くなり商品価値に
乏しいものとなる。また、場合によってはカプセル化工
程中に酵母菌が崩壊してしまい満足なカプセルが得られ
ないこともあり得る。 本発明のマイクロカプセルの製造方法において、酵母
細胞壁溶解酵素による処理を行なう時期は特に制限はな
く、カプセル化工程前に行っても後に行ってもよく、ま
た、疎水性液体のカプセル化と同時に行っても良い。 〈疎水性液体のカプセル化〉 本発明で用いられる酵母菌中に内包される疎水性液体
は、実質的に水不溶性の液体、もしくは加熱により液体
となるものであれば使用可能であり、綿実油、大豆油、
コーン油、オリーブ油、ヒマシ油、魚油、各種脂肪酸、
各種ステロイド等の動植物から抽出される油性液体、ま
た特に感圧複写紙用として利用する場合にはパラフィン
油、塩素化パラフィン、塩素化ジフェニル、ジブチルフ
タレート、ジオクチルフタレート、ジブチルマレエー
ト、o−ジクロルベンゼン、ジイソプロピルナフタレン
の如きアルキル化ナフタレン、1−フェニル−1−キシ
リルエタン等が挙げられる。これらの疎水性液体には目
的に応じ、染料、香料、薬理活性物質、食品素材、飼料
素材などを溶解もしくは分散され、得られたマイクロカ
プセルは感圧複写紙の他、化粧品、医薬品、食品、飼
料、農薬等に使用される。当該物質は、それ自体が水溶
性液体に非混和性の疎水性液体であれば上記疎水性液体
に分解、分散する事無く単独で使用することも可能であ
る。 疎水性液体のカプセル化は、疎水性液体と酵母菌体を
一定時間接触させることにより行う。具体的には例え
ば、酵母菌体を適当な分散剤を用い、水その他に分散さ
せた酵母菌分散液と疎水性液体を混合撹拌することによ
り行われる。混合撹拌時の温度は特に限定はされない
が、好ましくは20〜100℃である。時間は普通1時間以
上を要するが、内包される疎水性液体の量、温度などに
応じて適宜設定すれば良い。また、より均一な状態で酵
母菌と疎水性液体とを接触させるためにはアニオン系、
ノニオン系等の乳化剤を含む水溶液で疎水性液体を乳化
状態とした後添加混合した方が好ましい。更に必要に応
じpH調節剤、防腐剤、紫外線劣化防止剤、酸化防止剤、
耐水化剤その他を添加してカプセル化を行うこともでき
る。
The present inventors have studied to solve the above-mentioned problems of the encapsulation method using microorganisms, and have found that they can be solved by the following method. That is, the present invention is characterized by treating yeast with an enzyme that dissolves the cell wall of yeast in a method for producing microcapsules in which a hydrophobic liquid is encapsulated in yeast. Hereinafter, an enzyme that lyses the cell wall of yeast is abbreviated as yeast cell wall lysing enzyme. <Yeast> Yeast used in the present invention is a general term for microorganisms that grow by budding or division. Specifically, for example, Saccharomyces cereviche of the genus Saccharomyces
visiae) Saccharomyces rouxii Saccharomyces curlsbergensis
ces carlsbergensis) Candida utilis of the genus Candida (Candida utilis) Candida tropicallis (Candida lypolytica) Candida flaveri can be used. There are various shapes of yeast depending on the type, but it is preferable that the shape is as close to spherical as possible, and the particle size is 1 to 20 μm.
A range of m is preferred. These yeasts used in the present invention may be in a raw state, a dried state, or a dead state having no growth ability. The yeast may be one that has been appropriately treated as necessary. For example, in these mother bacteria, intracellular tissues such as enzymes and proteins soluble in water or polar solvents, amino acid components, sugar components and nucleic acid components are present, but a large amount of hydrophobic liquid is included. In addition, the yeast residue after extracting these intracellular components by various methods can also be used. These yeasts or yeast residues are dispersed in an aqueous solution using a suitable dispersant if necessary. <Yeast Cell Wall Lysing Enzyme> The yeast cell wall lysing enzyme used in the present invention may be any enzyme as long as it is a enzyme that dissolves the yeast cell wall, which is distinguished from an enzyme such as a protease that elutes yeast cell components. That is, the cell wall of yeast is composed of glucan, mannan, a complex of these polysaccharides and proteins, chitin, and the like, and any enzyme can be used as long as it is an enzyme that decomposes these constituent components. Examples of the cell wall lysing enzyme used in the present invention include glucanase, mannanase and chitinase. Among them, glucanase and mannanase are preferable, and an enzyme produced by a microorganism containing β-1,3 glucanase as a main component is particularly preferable. These enzymes may be used alone or in combination of two or more kinds. These enzymes can be obtained as reagents, or as the following enzymes containing these enzymes as the main components. Enzymes produced by Arthrobacter (Zymori Ace 20T manufactured by Kirin Brewery Co., Ltd.), enzymes produced by basidiomycete (Ketalase manufactured by Kumiai Chemical Co., Ltd.), enzymes produced by Achromobacter (YL- manufactured by Amano Pharmaceutical Co., Ltd.) 05). Also, Funatsu and Tsuru, "Lycolytic Enzymes," Kodansha (1977) P.16
Various cell wall lysing enzymes described in 9 to 191 and others can be used. <Lysis Treatment of Yeast Cell Wall> The lysis treatment is performed in order to partially dissolve the yeast cell wall to form a thin film or soften it. The degree depends on the desired physical strength and / or depending on the application of the manufactured microcapsules.
Alternatively, the cell wall is lysed so as to obtain a film property (for example, sustained release). That is, the yeast cell wall lysing enzyme is allowed to act on the yeast according to a conventional method, and the amount of the enzyme added so that the desired film strength and the like are obtained, the treatment conditions are set, or the enzyme reaction is performed when the desired film strength is obtained. By stopping. Normally, the optimum conditions for many enzymes are pH 4-9 and temperature 30-60 ° C, and the amount of enzyme added is 1 g of substrate.
Used in the range of 0.1-100 mg. Although the optimum reaction time is set according to the above conditions, it is usually about 10 minutes or more, preferably about 30 minutes to about 5 hours. To stop the enzyme reaction,
Centrifugation, a method of separating the yeast from the enzyme by washing, heating, pH adjustment, a method of deactivating the enzyme with a deactivating agent, or other suitable method may be used, but damage or deterioration of the yeast cell wall The method that does not occur is selected. At the specific stopping point of the enzyme reaction, it is sufficient to select the conditions that can obtain the microcapsules suitable for the intended use from the manufactured microcapsules. To what extent the yeast cell wall has dissolved, the enzymatic reaction causes the cell wall to decompose into sugars,
It can be judged by quantifying the total sugar amount present in the filtrate of the yeast dispersion liquid. For example, in the case of microcapsules for pressure-sensitive copying paper, it is necessary that the capsules are not destroyed by heat, humidity, or various printing and form work. In order to exhibit sufficient capsule robustness in these ordinary handling steps, the sugar elution rate (see Examples) should be about 0.5.
It is preferable to adjust to about 40%, particularly about 1% to about 20%. When the sugar elution rate is a value below this range, the effect of the present invention is not sufficiently exhibited, and the elution to a value higher than this range results in poor robustness of the capsule film obtained. When processed for pressure-sensitive copying paper, it is liable to break due to external factors such as heat, humidity, and solvent, resulting in poor commercial value. In addition, depending on the case, it is possible that yeast is disintegrated during the encapsulation process and a satisfactory capsule cannot be obtained. In the method for producing a microcapsule of the present invention, there is no particular limitation on the timing of the treatment with the yeast cell wall lysing enzyme, which may be performed before or after the encapsulation step, and is performed simultaneously with the encapsulation of the hydrophobic liquid. May be. <Encapsulation of Hydrophobic Liquid> The hydrophobic liquid encapsulated in the yeast used in the present invention may be a substantially water-insoluble liquid, or any liquid that becomes a liquid by heating, cottonseed oil, Soybean oil,
Corn oil, olive oil, castor oil, fish oil, various fatty acids,
Oily liquids extracted from animals and plants such as various steroids, and especially when used for pressure-sensitive copying paper, paraffin oil, chlorinated paraffin, chlorinated diphenyl, dibutyl phthalate, dioctyl phthalate, dibutyl maleate, o-dichloro. Benzene, alkylated naphthalene such as diisopropyl naphthalene, 1-phenyl-1-xylylethane and the like can be mentioned. Dyes, fragrances, pharmacologically active substances, food materials, feed materials, etc. are dissolved or dispersed in these hydrophobic liquids according to the purpose, and the obtained microcapsules are used for cosmetics, pharmaceuticals, foods, in addition to pressure-sensitive copying paper. Used for feed, agricultural chemicals, etc. If the substance itself is a hydrophobic liquid that is immiscible with the water-soluble liquid, it can be used alone without being decomposed or dispersed in the hydrophobic liquid. Encapsulation of the hydrophobic liquid is performed by contacting the hydrophobic liquid with yeast cells for a certain period of time. Specifically, for example, it is carried out by using a suitable dispersant for yeast cells, and mixing and stirring a yeast cell dispersion liquid in which water or the like is dispersed with a hydrophobic liquid. The temperature at the time of mixing and stirring is not particularly limited, but is preferably 20 to 100 ° C. The time is usually 1 hour or more, but it may be appropriately set depending on the amount of the encapsulated hydrophobic liquid and the temperature. In order to bring the yeast and the hydrophobic liquid into contact with each other in a more uniform state, an anionic system,
It is preferable that the hydrophobic liquid be emulsified with an aqueous solution containing a nonionic emulsifier and then added and mixed. Furthermore, if necessary, a pH adjusting agent, a preservative, an ultraviolet deterioration preventing agent, an antioxidant,
It is also possible to add a water-proofing agent and the like for encapsulation.

【実施例】【Example】

以下に、本発明を実施例により詳細に説明する。な
お、本発明は実施例に限定されるものではない。実施例
及び比較例中に示された酵母菌重量は、全て乾燥状態で
の重量である。 実施例1 [菌体内成分の溶出処理工程] 市販のパン酵母(鐘淵化学工業製生酵母[サッカロマ
イセス・セレビッシェ])10gを含む水分散液100gに、
エタノール10gを添加した後、回転式振盪培養機中で温
度40℃の条件下で24時間振盪し、菌体内の水溶性成分を
菌体外に溶出させた。遠心分離操作により溶出液と酵母
菌残渣を分離した後、溶出液の全量を105℃の乾燥器中
で水分を蒸発させたところ、6.0gの不揮発成分が残り、
初期添加酵母菌重量の60wt%が溶出したことが確認でき
た。 [細胞壁溶解処理工程] この酵母菌残渣をpH8.0に調整したリン酸−水酸化ナ
トリウムバファーで100gとし、その分散液中に酵母細胞
壁溶解酵素(キリンビール(株)製造、商品名ザイモリ
エース20T、主成分β−1,3−glucan laminalipentaohyd
rolase)を1mg添加し、40℃で2時間加温、撹拌処理を
行ない酵母細胞壁の溶解処理を行なった。処理終了後遠
心分離及び水洗を2度行ない酵素溶液を排除し全量を10
0gとした後、pHを10.0(ザイモリエースがほとんど作用
しないpH域)に調整した。 [カプセル化工程] 次に、乳化剤として0.5wt%のノニオン系界面活性剤
(花王アトラス製、商品名Tween−80)水溶液20g中に、
疎水性液体として3−N−メチルシクロヘキシルアミノ
−6−メチル−7−アニリノフルオラン(新日曹化学製
黒色発色染料、商品名PSD−150)1.1gを含む高沸点疎水
性液体(日本石油化学製、商品名ハイゾールSAS N−2
96)22gを激しく撹拌しながら添加し、平均粒径5μm
の疎水性液体の乳化液を得た。 この乳化液を酵母細胞壁溶解酵素で処理した酵母菌残
渣分散液中に添加した後、回転式振盪機中で温度40℃、
撹拌スピード200rpmの条件下で3時間振盪を続けた。そ
の結果、疎水性液体は全て酵母菌中に内包され、マイク
ロカプセル化が完了した。このマイクロカプセル分散液
をそのまま坪量40g/m2の上質紙に約5g/m2の塗抹量でバ
ーコートを施したところ、発色良好な感圧複写紙用上用
紙が得られた。 実施例2 実施例1において菌体内成分の溶出処理工程を経るこ
となく細胞壁溶解処理工程として実施例1で用いた市販
のパン酵母10gをpH7.0に調整した0.5%ポリアクリル酸
ナトリウム水溶液(東亜合成化学工業製、商品名アロン
T−40)中に添加し全量を100gに調整した後、酵母細胞
壁溶解酵素(商品名キタラーゼ、クミアイ化学(株)製
プロトプラスト化酵素、主成分β−1,3−glucanase)を
6mg添加し40℃で2時間加熱撹拌を行ない細胞壁の溶解
処理を行なった。処理終了後、遠心分離及び水洗を2度
行ない酵素溶液を排除した後、再度0.5%アロンT−40
水溶液で全量を100gとし、pHを10.0に調整した。以下、
実施例1と同様のカプセル化工程を経てマイクロカプセ
ルを得た。得られたマイクロカプセルを坪量40g/m2の上
質紙に塗抹することにより発色良好な感圧複写紙用上用
紙が得られた。 実施例3 実施例1と同様にして菌体内成分の溶出処理工程を経
て得られた酵母菌残渣を細胞壁溶解処理工程としてpH6.
5に調整したリン酸−水酸化ナトリウムバファーで100g
とし、その分散液中にザイモリエース20Tを8.0mg添加
し、40℃で3時間加温、撹拌処理を行い酵母細胞壁の溶
解処理を行った。処理終了後遠心分離及び水洗を2度行
ない酵素溶液を排除し全量を100gとした後、pHを10.0
(ザイモリエースがほとんど作用しないpH域)に調整し
た。次に実施例1と同様のカプセル化工程を経てマイク
ロカプセル及び感圧複写紙用上用紙を得た。 比較例 実施例1において、酵母細胞壁溶解処理工程を経るこ
となく酵母菌残渣分散液中に疎水性液体の乳化液を添加
し同様にカプセル化を3時間行なったが、得られた酵母
菌分散液中には酵母菌体内に内包しきれなかった乳化粒
子が多量に残存していた。この分散液をそのまま実施例
1と同様にして感圧複写紙用上用紙を得た。 上記実施例及び比較例で得られた感圧複写紙用上用紙
の発色性とマイクロカプセルの堅牢性を次の方法により
評価比較した。 発色性:上用紙を市販の感圧複写紙用下用紙(三菱製紙
製 三菱NCR紙スーパー品N−40)と対向させ、線圧15K
g/cmの圧力が加えられた1対のロール間に1回通過させ
て発色させ、1時間後の発色部分の発色濃度を市販の色
差計(日本電色工業(株)製カラーディファレンシャル
メーターND−101DP型)を用いて測定した。(値が小さ
いほど発色濃度が高いことを示す) 堅牢性:上用紙と発色性試験で用いたものと同じ下用紙
を塗布綿が対向するように重ね合わせ、0.1kg/cm2の軽
荷重を加え、105℃の雰囲気で12時間放置した後の下用
紙面対向部分の反射率を測定し、発色部分の反射率とし
た。また、上用紙と対向させる事無く下用紙のみを同様
の条件下で熱処理した際の下用紙面の反射率を未処理部
分の反射率とし、下式により堅牢性の値を算出した。評
価は値が大きいものほどマイクロカプセル皮膜の堅牢性
は優れている。すなわち皮膜の堅牢性に劣るものは、熱
処理中にマイクロカプセルが破壊され内包されていた染
料が対向する下用紙に転移する結果、反射率は低い値が
得られ、堅牢性の値は小さくなる。 糖溶出率:酵母細胞壁の溶解処理を施した分散液のろ液
中の全糖量(グルコース換算値)をフェノール硫酸法で
測定し、次の算式により糖溶出率を求めた。糖溶出率の
値が大きいものほど細胞壁の溶解が進行していることを
示している。 以上の測定方法に基づき、各シートを評価した結果を
表1に示す。
Hereinafter, the present invention will be described in detail with reference to Examples. The present invention is not limited to the embodiments. The yeast weights shown in Examples and Comparative Examples are all weights in a dry state. Example 1 [Elution process of intracellular components] To 100 g of an aqueous dispersion containing 10 g of commercially available baker's yeast (live yeast [Kanabuchi Kagaku Kogyo [Saccharomyces cerevisia]]),
After adding 10 g of ethanol, the mixture was shaken in a rotary shaker under the condition of a temperature of 40 ° C. for 24 hours to elute the water-soluble components in the cells outside the cells. After separating the eluate and the yeast residue by centrifugation, the total amount of the eluate was evaporated in a dryer at 105 ° C to leave 6.0 g of non-volatile components,
It was confirmed that 60 wt% of the weight of the initially added yeast was eluted. [Cell Wall Lysis Treatment Step] The yeast residue was adjusted to 100 g with phosphoric acid-sodium hydroxide buffer adjusted to pH 8.0, and a yeast cell wall lysing enzyme (Kirin Brewery Co., Ltd., trade name Zymori Ace 20T) was added to the dispersion. Main component β-1,3-glucan laminalipentaohyd
rolase) was added and the yeast cell wall was lysed by heating and stirring at 40 ° C. for 2 hours. After the treatment, centrifuge and wash twice to eliminate the enzyme solution and bring the total volume to 10
After adjusting to 0 g, the pH was adjusted to 10.0 (pH range where Zymolyase hardly acts). [Encapsulation step] Next, as an emulsifier, in a solution of 0.5 wt% nonionic surfactant (manufactured by Kao Atlas, trade name Tween-80) 20 g,
A high-boiling hydrophobic liquid containing 1.1 g of 3-N-methylcyclohexylamino-6-methyl-7-anilinofluorane (black color dye manufactured by Shin Nisso Chemical Co., Ltd., trade name PSD-150) as a hydrophobic liquid Product name: Hysol SAS N-2
96) Add 22 g with vigorous stirring, average particle size 5 μm
To obtain an emulsified liquid of a hydrophobic liquid. This emulsion was added to the yeast residue dispersion treated with the yeast cell wall lysing enzyme, and the temperature was 40 ° C in a rotary shaker,
Shaking was continued for 3 hours under a stirring speed of 200 rpm. As a result, all of the hydrophobic liquid was encapsulated in yeast and microencapsulation was completed. When this microcapsule dispersion was applied as it was to a high quality paper having a basis weight of 40 g / m 2 with a bar coat at a smearing amount of about 5 g / m 2, an excellent paper for pressure-sensitive copying paper with good color development was obtained. Example 2 10% of the commercially available baker's yeast used in Example 1 as a cell wall lysis treatment step in Example 1 without passing through the intracellular component elution treatment step was adjusted to pH 7.0, and a 0.5% sodium polyacrylate aqueous solution (Toa Synthetic Chemical Industry Co., Ltd., trade name Aron T-40) was added to adjust the total amount to 100 g, and then yeast cell wall lysing enzyme (trade name: Kitalase, Kumiai Chemical Co., Ltd. protoplast-forming enzyme, main component β-1,3) −glucanase)
6 mg was added, and the cells were lysed by heating and stirring at 40 ° C. for 2 hours. After the treatment, centrifugation and washing with water were performed twice to remove the enzyme solution, and then 0.5% Aron T-40 was added again.
The total amount was adjusted to 100 g with an aqueous solution, and the pH was adjusted to 10.0. Less than,
Microcapsules were obtained through the same encapsulation process as in Example 1. By smearing the obtained microcapsules on a high-quality paper having a basis weight of 40 g / m 2 , an upper paper for pressure-sensitive copying paper with good color development was obtained. Example 3 The yeast residue obtained through the elution treatment step of intracellular components in the same manner as in Example 1 was used as a cell wall lysis treatment step at pH 6.
100g with phosphoric acid-sodium hydroxide buffer adjusted to 5
Then, 8.0 mg of Zymory Ace 20T was added to the dispersion, and the yeast cell wall was dissolved by heating and stirring at 40 ° C. for 3 hours. After completion of the treatment, centrifugation and washing with water were carried out twice to remove the enzyme solution so that the total amount was 100 g, and the pH was 10.0.
(PH range where Zymolyce hardly acts) was adjusted. Next, the same encapsulation process as in Example 1 was performed to obtain microcapsules and upper paper for pressure-sensitive copying paper. Comparative Example In Example 1, the hydrophobic liquid emulsion was added to the yeast residue dispersion liquid without the yeast cell wall lysis treatment step, and encapsulation was performed for 3 hours in the same manner. A large amount of emulsified particles that could not be completely encapsulated in the yeast cells remained inside. Using this dispersion as it was, an upper sheet for pressure-sensitive copying paper was obtained in the same manner as in Example 1. The coloring property of the upper paper for pressure-sensitive copying paper and the fastness of the microcapsules obtained in the above Examples and Comparative Examples were evaluated and compared by the following methods. Color development: The upper paper is made to face the commercially available lower paper for pressure-sensitive copying paper (Mitsubishi NCR paper super product N-40 manufactured by Mitsubishi Paper Mills), and the line pressure is 15K.
Color is passed by passing it once between a pair of rolls to which a pressure of g / cm is applied, and after 1 hour, the color density of the color-developed portion is measured by a commercially available color difference meter (a color differential meter ND manufactured by Nippon Denshoku Industries Co., Ltd.). -101DP type). (The smaller the value, the higher the color density.) Robustness: Overlay the upper paper and the same lower paper used in the color development test with the coated cotton facing each other and apply a light load of 0.1 kg / cm 2. In addition, the reflectance of the portion facing the lower paper surface was measured after leaving it in the atmosphere of 105 ° C. for 12 hours, and the reflectance of the colored portion was determined. Further, the reflectance of the untreated portion was defined as the reflectance of the surface of the lower sheet when only the lower sheet was heat-treated under the same conditions without facing the upper sheet, and the fastness value was calculated by the following formula. The larger the evaluation value, the better the robustness of the microcapsule film. That is, when the film has poor fastness, the microcapsules are destroyed during the heat treatment and the dye contained therein is transferred to the opposite lower sheet, so that the reflectance is low and the fastness is low. Sugar elution rate: The total sugar amount (glucose conversion value) in the filtrate of the dispersion liquid having the yeast cell wall dissolved therein was measured by the phenol-sulfuric acid method, and the sugar elution rate was determined by the following formula. The larger the sugar elution rate is, the more the cell wall is dissolved. Table 1 shows the results of evaluation of each sheet based on the above measuring method.

【発明の効果】【The invention's effect】

本発明により、酵母菌を利用したマイクロカプセルに
おいて、その皮膜強度を自由に制御することが可能とな
った。例えば本発明によって製造されるマイクロカプセ
ルを感圧紙用に応用した場合、コアセルベーション法や
insitu法と比較しても何等遜色のない発色性と皮膜の堅
牢性が得られるようになった。さらに、カプセル化前に
マイクロカプセルの壁材となる酵母菌を酵母細胞壁溶解
酵素で処理することにより、その操作を行なわない場合
に比べ摂取される疎水性液体が多量かつ迅速に内包され
ることが可能になった。 加えて、マイクロカプセルの皮膜特性を自由に制御す
ることが可能となり、内包物の徐放性が制御できるよう
になったので前述の種々の用途において従来以上に有効
に適用できるようになった。
According to the present invention, it becomes possible to freely control the film strength of a microcapsule using yeast. For example, when the microcapsules produced by the present invention are applied to pressure-sensitive paper, the coacervation method or
Even when compared with the in situ method, it is now possible to obtain color development and film fastness comparable to those of the in situ method. Furthermore, by treating the yeast, which is the wall material of the microcapsule, with the yeast cell wall lysing enzyme before encapsulation, a large amount of the ingested hydrophobic liquid can be rapidly encapsulated as compared with the case where the operation is not performed. It became possible. In addition, the film characteristics of the microcapsules can be freely controlled, and the sustained-release property of the encapsulated substance can be controlled. Therefore, the microcapsule can be more effectively applied to various applications described above than before.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 B41M 5/165 C12N 1/14 Z 8828−4B (C12N 1/14 C12R 1:865) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Office reference number FI technical display location B41M 5/165 C12N 1/14 Z 8828-4B (C12N 1/14 C12R 1: 865)

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】酵母菌と疎水性液体とを接触させて得られ
る酵母菌体内に疎水性液体を内包してなるマイクロカプ
セルの製造方法において、酵母菌体内の水溶性成分を菌
体外に溶出した、又は未溶出の酵母菌体を酵母菌の細胞
壁を溶解する酵素で処理したものを疎水性液体とを接触
させることを特徴とするマイクロカプセルの製造方法。
1. A method for producing a microcapsule obtained by contacting a yeast with a hydrophobic liquid, which comprises the hydrophobic liquid in the yeast cell, wherein a water-soluble component in the yeast cell is eluted to the outside of the cell. A method for producing microcapsules, which comprises contacting a treated or uneluted yeast cell with an enzyme that dissolves the yeast cell wall with a hydrophobic liquid.
【請求項2】特許請求の範囲第1項記載の方法におい
て、該酵母菌体を該酵素で処理し、次いでかく処理した
酵母菌体を疎水性液体と接触させることよりなるマイク
ロカプセルの製造方法。
2. The method according to claim 1, wherein the yeast is treated with the enzyme, and the yeast thus treated is then contacted with a hydrophobic liquid. .
JP2235636A 1990-06-05 1990-09-07 Microcapsule manufacturing method Expired - Lifetime JPH0832225B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2235636A JPH0832225B2 (en) 1990-09-07 1990-09-07 Microcapsule manufacturing method
DE69113682T DE69113682T2 (en) 1990-06-05 1991-06-05 Process for the production of microcapsules.
EP91305102A EP0460945B1 (en) 1990-06-05 1991-06-05 Process for producing microcapsules
US08/178,604 US5521089A (en) 1990-06-05 1994-01-07 Process for treating yeast with B-1, 3-glucanase to produce microcapsules for enclosing hydrophobic liquids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2235636A JPH0832225B2 (en) 1990-09-07 1990-09-07 Microcapsule manufacturing method

Publications (2)

Publication Number Publication Date
JPH04117245A JPH04117245A (en) 1992-04-17
JPH0832225B2 true JPH0832225B2 (en) 1996-03-29

Family

ID=16988959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2235636A Expired - Lifetime JPH0832225B2 (en) 1990-06-05 1990-09-07 Microcapsule manufacturing method

Country Status (1)

Country Link
JP (1) JPH0832225B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238355B1 (en) 1999-02-26 2007-07-03 Kirin Beer Kabushiki Kaisha Coated material and process for producing the coated material
KR100454094B1 (en) * 2001-06-29 2004-10-26 주식회사농심 Process for stable encapsulation of substrate in liquid and paste with long lasting flavor made by this process
ES2335579T5 (en) 2001-11-15 2021-05-27 San Ei Gen Ffi Inc Microcapsules and Oral Compositions Containing Them
PL1711058T3 (en) 2004-01-23 2022-02-07 Eden Research Plc Methods of killing nematodes comprising the application of a terpene component
PT2338332E (en) 2004-05-20 2014-05-15 Eden Research Plc OCA GLUCAN PARTICLE OR CELLULAR WALL PARTICLE THAT ENCAPSES A TERPENE COMPONENT
US7740861B2 (en) 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
ES2375995T3 (en) 2004-09-17 2012-03-08 University Of Massachusetts COMPOSITIONS AND THEIR USES FOR DEFICIENCIES OF LISOSOMAL ENZYME.
EP1850683B1 (en) * 2005-02-10 2013-11-06 Firmenich SA Heated food product with coating of encapsulated flavours

Also Published As

Publication number Publication date
JPH04117245A (en) 1992-04-17

Similar Documents

Publication Publication Date Title
US5521089A (en) Process for treating yeast with B-1, 3-glucanase to produce microcapsules for enclosing hydrophobic liquids
KR100418544B1 (en) Encapsulated product
CA1301682C (en) Microbial encapsulation
JPH0732870B2 (en) Microcapsule manufacturing method
US5288632A (en) Encapsulation of material in microbial cells
EP0470872B1 (en) Polysaccharide article and use thereof
EP0085805B1 (en) Process for encapsulating substances by means of microorganisms, and the encapsulated products obtained thereby
JPH0832225B2 (en) Microcapsule manufacturing method
JPH1076155A (en) Non-lipid soluble substance-containing microcapsule and method for producing the same
Freeman et al. Immobilization of “disguised” yeast in chemically crosslinked chitosan beads
JPH0732871B2 (en) Microcapsule manufacturing method
JPS6388033A (en) Preparation of microcapsule
JPH0515770A (en) Microcapsule manufacturing method
JPH0549035B2 (en)
JP3034069B2 (en) Manufacturing method of microcapsules
Yi et al. Encapsulation of chlorophyllase in hydrophobically modified hydrogel
JP2978299B2 (en) Manufacturing method of microcapsules
JPH05138010A (en) Microcapsule manufacturing method
JPS62186937A (en) Method for manufacturing microcapsules
Gajjar et al. Activation and stabilization of enzymes entrapped into reversed micelles: studies on hydrolyzing enzymes-protease and α-amylase
US2480090A (en) Fungal lipase
Nitoda et al. Improved bioassay method for Spodoptera litura chitinase inhibitors using a colloidal chitin powder with a uniform particle size as substrate
JPH04313341A (en) Production of colored microcapsule
HK1018026B (en) Encapsulated product
JPH02241537A (en) Water retaining agent-containing microcapsule